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Abstract
Neoadjuvant chemoradiation therapy (CRT) is increasingly the standard of care for locally advanced oesophageal cancer. A
complete pathological response to CRT is associated with a favourable outcome. Radiation therapy is important for local
tumour control, however, radioresistance remains a substantial clinical problem. We hypothesise that alterations in
mitochondrial function and energy metabolism are involved in the radioresistance of oesophageal adenocarcinoma (OAC).
To investigate this, we used an established isogenic cell line model of radioresistant OAC. Radioresistant cells (OE33 R)
demonstrated significantly increased levels of random mitochondrial mutations, which were coupled with alterations in
mitochondrial function, size, morphology and gene expression, supporting a role for mitochondrial dysfunction in the
radioresistance of this model. OE33 R cells also demonstrated altered bioenergetics, demonstrating significantly increased
intracellular ATP levels, which was attributed to enhanced mitochondrial respiration. Radioresistant cells also demonstrated
metabolic plasticity, efficiently switching between the glycolysis and oxidative phosphorylation energy metabolism
pathways, which were accompanied by enhanced clonogenic survival. This data was supported in vivo, in pre-treatment
OAC tumour tissue. Tumour ATP5B expression, a marker of oxidative phosphorylation, was significantly increased in patients
who subsequently had a poor pathological response to neoadjuvant CRT. This suggests for the first time, a role for specific
mitochondrial alterations and metabolic remodelling in the radioresistance of OAC.
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Introduction
Cancer of the oesophagus occurs worldwide [1] and despite
recent advances in diagnosis and treatment, prognosis is poor with
5-year survival rates between 20 and 40% [2]. Recently, there has
been a dramatic epidemiological shift in the incidence of
oesophageal adenocarcinoma (OAC), which is now the dominant
subtype in many western populations [3,4]. Neoadjuvant chemor-
adiation therapy (CRT) followed by surgery is increasingly the
standard of care for oesophageal cancer patients treated with
curative intent [5,6]. There is significant evidence that the tumour
response to neoadjuvant CRT is the best predictor of both disease-
free and overall survival, with 5-year survival rates increased to
60% for patients achieving a complete pathological response
(pCR) [7,8].
Radiation therapy exerts its effects locoregionally and is
important for local tumour control. Whilst higher pCR rates are
achieved with CRT than with induction chemotherapy alone
[9,10], only ,30% of patients achieve a pCR [7,11]. The
elucidation of underlying molecular mechanisms of radioresistance
and the identification of biomarkers that predict those patients
who will respond to treatment is imperative to improving both the
efficacy of treatment and survival rates.
DNA is the primary target of ionising radiation (IR). The
mitochondrial genome is the only other cellular source of genetic
material and is extremely susceptible to oxidative damage [12],
making it a likely target for IR-induced damage. In addition to
their essential role in regulating ATP production via oxidative
phosphorylation, mitochondria also regulate other key processes
including cell death and the cellular redox environment [13], both
of which have been implicated in the cellular response to
radiation. IR induces a complex cellular response involving
multiple pathways [14,15], therefore, mechanisms of radioresis-
tance are likely to be polygenic in nature and energy-requiring.
Modification of energy metabolism is an emerging hallmark of
cancer [16]. Whilst the best known alteration is the so called
‘Warburg effect’, whereby tumour cells demonstrate a reliance on
glycolysis even in the presence of O2 [17], there is accumulating
evidence to suggest that a wide spectrum of bioenergetic profiles
exist in human cancers [18,19]. This suggests that the ability of a
tumour to adapt and remodel energy metabolism in response to
both internal and external stimuli, may be an important
mechanism underlying cancer initiation, progression and response
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to anti-cancer therapy. The central role of the mitochondria in
regulating energy production suggests that alterations in mito-
chondrial function and energy production may be important for
the cellular response to radiation, however, this remains under-
investigated.
In this study, we demonstrate alterations in mitochondrial
function and bioenergetics in both an isogenic cell line model of
radioresistant OAC and OAC tumour biopsies, supporting a role
for mitochondrial dysfunction in the radioresistance of OAC.
Materials and Methods
Cells lines and cell culture
The human oesophageal adenocarcinoma cell line OE33 was
obtained from the European collection of cell cultures. OE33 P
and OE33 R cells were generated, cultured and characterised in
our laboratory as previously described [20].
Irradiation
Irradiation was performed using a Gulmay Medical X-ray
generator, (RS225) (Gulmay Medical), at a dose rate of 3.25 Gray
(Gy) per min.
ROS and mitochondrial mass measurement
ROS and mitochondrial mass were measured by high content
screening using CM-H2DCFDA (20 mM) and MitoTracker Green
FM (300 nM) fluorescent probes (Invitrogen), respectively. Cells
were seeded in 96-well plates at a density of 15,000 cells/well.
Medium was removed and cells were incubated for 30 min at
37uC with respective probes in staining buffer (130 mM NaCl,
5 mM KCl, 1 mM Na2HPO4, 1 mM CaCl2, 1 mM MgCl2 and
25 mM Hepes, pH 7.4). Cells were counterstained with Hoechst
33342 (Invitrogen) nuclear stain (3 mg/mL in staining buffer) for
30 min at 37uC. Cells were analyzed on an In Cell analyzer 1000
(GE Healthcare). Five fields of view/well were acquired using a
106objective. Nuclear staining with Hoescht 33342 was detected
using an excitation filter of 360 nm and emission filter of 535 nm.
CM-H2DCFDA and Mitotracker green FM were detected using
an excitation filter of 480 nm and emission filter of 535 nm. Mean
cellular fluorescence intensity was used to calculate ROS and
mitochondrial mass using In Cell analyzer 1000 workstation image
analysis software, which allowed normalization of the data to cell
numbers.
Random Mutation Capture (RMC) assay
The RMC assay was carried out on cells at a confluency of 80%
in T25 cm2 flasks. DNA isolation, TaqaI digestion, qPCR and
sequencing was carried out as previously described [21]. All
mutations identified occur at a single 59-TCGA-39 sequence,
located at base pairs 1216 to 1220 of the mitochondrial genome.
RNA isolation
Total RNA was isolated using RNeasy Plus Mini Kit (Qiagen)
as per the manufacturer’s instructions. RNA was quantified using
a Nanodrop 1000 spectrophotometer v3.3 (Thermo Scientific).
Mitochondria and metabolism PCR gene arrays
RNA was reversed transcribed to cDNA using a First Strand
cDNA synthesis kit (Qiagen), as per the manufacturer’s instruc-
tions. cDNA samples were applied to RT2 Profiler PCR Arrays
(Qiagen), and qPCR was performed as per the manufacturer’s
instructions using an ABI Prism 7900 HT real-time thermal cycler
(Applied Biosystems). Data was analyzed by the 22DDCt method
using SDS RQ 1.2 relative quantification software (Applied
Biosystems). One sample was set as the calibrator for the analysis.
Transmission electron microscopy
OE33 P and OE33 R cells (pre and 24 h post irradiation with
2 Gy) were fixed with gluteraldehyde (3% in 0.05 M Potassium
Phosphate buffer, pH 6.8) for 1 h at room temperature. Samples
were processed and analyzed using a Jeol JEM2100 LaB6
(operated at 100 Kv). Digital images were obtained using an
AMT XR80 capture system and ImageJ software.
Crystal violet assay
Cells were fixed with 1% gluteraldehyde (Sigma-Aldrich) for
20 min at room temperature. The fixative was removed and cells
were stained with crystal violet (0.1% in PBS) for 30 min at room
temperature. Cells were washed with H2O and allowed to air dry.
Cells were incubated with Triton X (1% in PBS) on a shaker for
15 min at room temperature. Absorbance was read at 595 nm
using a Wallac Victor2 1420 multi-label counter (Perkin Elmer).
Intracellular ATP measurement
OE33 P and OE33 R cells (pre and 24 h post irradiation with
2 Gy) were seeded in 96-well white-walled plates (15,000 cells/
well) and allowed to adhere overnight. Relative intracellular ATP
levels were measured using the luminescence-based ATPLite assay
system (Perkin Elmer), as per the manufacturer’s instructions.
Luminescence was measured using a Wallac Victor2 1420
multilabel counter. An additional plate was set up concurrently
and a crystal violet assay was performed to normalize ATP
measurements to cell number.
OCR and ECAR measurements
Oxygen consumption rates (OCR) and extracellular acidifica-
tion (ECAR) rates were measured before and after treatment with
oligomycin (2 mg/mL, Seahorse Biosciences), antimycin (2.6 mM,
Seahorse Biosciences) and 2-Deoxyglucose (55 mg/mL, Sigma),
using a Seahorse XF24 analyzer (Seahorse Biosciences). Briefly,
irradiated and ‘mock’ irradiated OE33 P and OE33 R cells were
seeded at 18,000 and 20,000 cells/well, respectively, in a 24-well
cell culture XF microplate (Seahorse Biosciences) and allowed to
adhere overnight. Cells were washed with assay medium
(unbuffered DMEM supplemented with 5 mM glucose, pH 7.4)
before incubation with assay medium (0.5 mL) for 1 h at 37uC in a
CO2- free incubator. Four baseline OCR and ECAR measure-
ments were taken over 28 min. Two OCR and ECAR measure-
ments were taken over 14 min following injection of antimycin,
oligomycin or 2-deoxyglucose. All measurements were normalized
to cell number using the crystal violet assay. ATP turnover was
calculated by dividing the percentage of OCR linked to
mitochondrial respiration by the percentage of OCR linked to
ATP synthesis. Proton leak was calculated by subtracting the % of
OCR linked to ATP turnover from 100%.
Clonogenic assay
Cells were collected by trypsinisation, counted and seeded at
optimised cell seeding densities (1.56103–3.06104 cells/well) in 6-
well plates and allowed to adhere overnight. Cells were treated
with oligomycin (2 mg/mL) or DMSO in complete medium for
1.5 h. Media was removed and replaced with complete medium,
and cells were incubated at 37uC in 5% CO2/95% air for 9–12
days. Colonies were fixed and counted as described previously
[20].
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Ethics statement, patients, sample collection and
treatment
Following ethical approval (Joint St James’s Hospital/AMNCH
ethical review board) and written informed consent, diagnostic
biopsy specimens were taken from patients with a diagnosis of
operable OAC, by a qualified endoscopist prior to neoadjuvant
therapy. Histologic confirmation of tumour tissue in biopsies was
performed by a pathologist using routine hematoxylin and eosin
staining. Patients received a complete course of neoadjuvant CRT.
Chemotherapy consisted of 2 courses of 5- fluorouracil (5-FU) and
cisplatin, as previously described [22]. Patients received 40.05 Gy
in 15 daily fractions (2.67 Gy/fraction) over 3 weeks as previously
described [22]. Surgical resection was performed within 1 month
of completing the CRT regimen. All resected esophagectomy
specimens were assessed by an experienced pathologist. Tumour
response to treatment was assigned 1 of 5 tumour regression
grades (TRG), as previously described [23]. Good responders were
classified as patients achieving a TRG of 1 or 2, whilst poor
responders were classified as patients having a TRG of 3, 4 or 5, as
previously described [24].
Immunohistochemistry
Tissue microarrays (TMA) were constructed from formalin-
fixed paraffin-embedded pre-treatment tumour biopsies using
0.6 mm cores. Immunohistochemistry was performed using a
Vectastain ABC Kit (Elite), as per the manufacturer’s instructions.
Slides were deparaffinised, rehydrated and heated-antigen retriev-
al was performed using Trilogy solution (Cell Marque Corpora-
tion). Endogenous peroxidase activity was blocked using hydrogen
peroxide (3%) for 30 min and sections were blocked using horse/
goat serum and incubated with either mouse-anti-human ATP5B
antibody (Santa Cruz Biotechnology, 1:1000 dilution), mouse-anti-
human HSP60 (Abcam, 1:400 dilution), rabbit-anti-human PKM2
(Abgent, 1:100 dilution) or rabbit-anti-human GAPDH (AbDser-
otec, 1:100 dilution) for 1 h at room temperature. Sections were
then incubated with secondary antibody/horseradish peroxidise
for 30 min at room temperature. Diaminobenzidine (Sigma) was
used to visualize staining and sections were counter-stained with
haematoxylin, dehydrated and mounted. Stained sections were
scanned using a scanscope XT digital scanner and ImageScope
software (Aperio Technologies). Expression was assessed by
scoring positive cell count and intensity in the epithelium and
stroma by 2 reviewers who were blinded to the TRG status of the
patient. Positive cell count was assessed using 6 categories (0%,
10%, 25%, 50%, 75%, 90% and 100%). Intensity was assessed
using a scale of 0, 1, 2 and 3 which correlated with negative, weak,
medium and strong staining, respectively.
ATP5B qPCR
Total RNA (1 mg) was reverse transcribed to cDNA using
random hexamers (Invitrogen) and BioScript (Bioline). qPCR was
performed using a TaqMan primer probes (Applied Biosystems)
and 18S was used as an endogenous control for data normaliza-
tion. Data was analysed using SDS 2.3 and SDS RQ 1.2 relative
quantification software (Applied Biosystems). One control sample
was set as the calibrator for the analysis.
Western blotting
Cells were lysed in RIPA buffer (50 mM Tris, pH 7.5, 150 mM
NaCl, 2 mM EDTA, pH 8.0, 0.5% Triton X-100, protease
inhibitor cocktail, 1 mM PMSF and 1 mM Na3VO4). Sample
protein concentrations were quantified using the BCA assay
(Pierce). Proteins (30 mg) were resolved on a 12% polyacrylamide
gel and transferred to polyvinylidene fluoride membranes.
Immunoblots were incubated with mouse anti-human ATP5B
antibody (Santa Cruz Biotechnology), 1:500 dilution or rabbit
anti-human b-actin (Abcam), 1:2,000 dilution, followed by
incubation with HRP-labelled donkey anti-mouse (R&D systems)
or goat anti-rabbit (Santa Cruz Biotechnology) IgG antibodies,
respectively. Detection was performed using SuperSignal West
Pico chemiluminescent substrate kit (Thermo Scientific). Densito-
metric analysis was performed using ImageJ software. b-actin was
used as an endogenous control for data normalization.
Statistical analysis
Statistical analysis was carried out using GraphPad InStat v3
(GraphPad software Inc). Significance was determined by two-
tailed Students t-test for normally distributed data. For all
statistical analysis, differences were considered to be statistically
significant at p,0.05.
Results
OE33 R cells demonstrate increased mutagenesis and
altered mitochondrial function
To investigate the role of mitochondrial alterations in the
radioresistance of OAC, we used an isogenic cell line model of
radioresistant OAC, previously generated in our laboratory [20].
The radioresistant OE33 R subline, which was generated by
chronic irradiation with clinically-relevant fractionated doses of
2 Gy X-ray radiation, displays enhanced resistance to radiation
when compared with its radiosensitive OE33 parent (OE33 P) cell
line [20]. These two cell lines, of the same origin but with distinctly
different radiosensitivities, provide a unique model with which to
investigate the molecular determinants of response to radiation in
OAC.
Given the close proximity of the mitochondria to potential
endogenous sources of ROS via the electron transport chain, we
assessed the basal frequency of random mutations in the
mitochondrial genome of both radiosensitive OE33 P and
radioresistant OE33 R cells, using the random mutation capture
assay. OE33 R cells demonstrated a significant (p=0.033) increase
in basal levels of random mitochondrial mutations, when
compared to OE33 P cells (Figure 1A). All mutations occurred
within a known 4-bp sequence located within the 12S ribosomal
gene. Sequencing data showed a predominance of C.T and G.
T transitions in OE33 P cells, with A.G transitions also present in
OE33 R cells. There was no significant alteration in random
mutation levels in either cell line at 24 h post irradiation (data not
shown).
We then investigated if this increased basal mitochondrial
mutagenesis in OE33 R was accompanied by alterations in
mitochondrial function. ROS and mitochondrial mass, which are
surrogates of mitochondrial function were assessed both basally
and at 24 h post irradiation with 2 Gy. This time point was chosen
as we have previously demonstrated alterations in pathways
implicated in the radioresponse at this time point [20]. Basal ROS
levels were significantly increased in OE33 R, when compared to
OE33 P (p=0.048) (Figure 1B). Interestingly, at 24 h post
irradiation ROS were significantly elevated in OE33 P cells
(p=0.035), an effect not observed in OE33 R cells. Increases in
ROS in OE33 P following irradiation was coupled with a
significant increase in mitochondrial mass (p=0.043) (Figure 1C),
which was not observed in OE33 R cells. These findings suggest
that mitochondrial function is altered in OE33 R cells.
Mitochondrial Alterations and Radioresistance
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Mitochondrial number and morphology is altered in
OE33 R cells
The ultrastructure of OE33 P and OE33 R cells was assessed by
transmission electron microscopy, basally and at 24 h post
irradiation with 2 Gy. OE33 R cells appeared to have increased
basal numbers of mitochondria, when compared to OE33 P cells
(Figures 2A, B). The number of mitochondria in OE33 P appeared
to increase at 24 h post irradiation, when compared to basal levels
(Figure 2C), supporting the previously demonstrated alterations in
mitochondrial mass. Furthermore, the mitochondrial morphology
in irradiated OE33 P cells was altered with a similar phenotype to
that seen in OE33 R cells. Radiation did not appear to alter
mitochondrial number or morphology in OE33 R cells
(Figure 2D).
At high power magnification, the basal mitochondrial mor-
phology in OE33 P and OE33 R demonstrated striking
alterations. Mitochondria in OE33 P cells displayed the traditional
mitochondrial structure, with cristae clearly visible (Figure 2E). In
contrast, OE33 R mitochondria were much more elongated and
condensed (Figure 2F). This increased density suggests that the
mitochondria in OE33 R cells may have increased biochemical
and metabolic activity. These alterations further support a role for
mitochondrial dysfunction in the radioresistance of this model.
OE33 R cells have increased energy and mitochondrial
metabolism rates
The observed alterations in mitochondrial function and
ultrastructural morphology in OE33 R cells were further
supported at the gene level, with basal expression of 15 genes
involved in regulating mitochondrial function and energy metab-
olism altered $1.5-fold in OE33 R cells, when compared to OE33
P (Figure 3A). Interestingly, all 5 altered energy metabolism-
associated genes (namely, ATP5G1, ATP5G3, ATPV0A2, NDUFC2
and NDUFS3) were increased in OE33 R cells, supporting
increased metabolic activity in these cells. To investigate if this
correlated with increased energy, we measured intracellular ATP
levels in both cell lines, basally and at 24 h post irradiation with
2 Gy. Supporting what we had seen at the ultrastructural and gene
expression level, OE33 R cells had significantly increased basal
intracellular ATP levels (p=0.004), when compared to OE33 P
cells (Figure 3B). Irradiation with 2 Gy significantly reduced ATP
levels at 24 post irradiation in OE33 P cells (p=0.004), however,
this was not observed in OE33 R cells. This suggests that OE33 R
cells can more efficiently maintain intracellular energy levels
following cytotoxic insult.
To investigate if the increased ATP levels in OE33 R were due
to alterations in energy metabolism, we measured the two major
energy pathways, oxidative phosphorylation and glycolysis, in
OE33 P and OE33 R using the Seahorse XF analyzer. This allows
the simultaneous measurement of OCR, which is a measure of
oxidative phosphorylation and the ECAR, a product of glycolysis,
in live cells in real-time. OE33 R cells had a significantly increased
Figure 1. Radioresistant OE33 R cells have increased mito-
chondrial mutagenesis and altered mitochondrial function. (A)
OE33 R cells demonstrate significantly elevated basal levels of random
mitochondrial mutations, when compared to OE33 P. (B) OE33 R cells
have significantly increased basal ROS levels, when compared to OE33
P. ROS levels are significantly increased in OE33 P cells at 24 h post
irradiation with 2 Gy. (C) Mitochondrial mass is significantly increased in
OE33 P cells at 24 h post irradiation with 2 Gy, this effect is not seen in
OE33 R. Data are presented as mean6SEM from 3 independent
experiments. Statistical analysis was performed by 2-tailed Student’s t-
test, *P,0.05.
doi:10.1371/journal.pone.0100738.g001
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basal OCR when compared to OE33 P cells (p=0.02) (Figure 3C),
suggesting a mechanism for the increased levels of intracellular
ATP in radioresistant cells. OE33 R cells demonstrated a trend
towards increased basal ECAR, when compared to OE33 P (222
versus 173 mpH/min, respectively), however, this was not
statistically significant (Figure 3D). Taken together, these data
suggest that OE33 R cells are more metabolically active, which
may be a mechanism underlying their radioresistance.
OE33 R cells have altered bioenergetics
To further investigate the alterations in oxidative phosphory-
lation in OE33 R cells, we treated OE33 P and OE33 R cells with
two specific inhibitors of the electron transport chain, antimycin
and oligomycin. Antimycin inhibits complex III, effectively
inhibiting all mitochondrial respiration and therefore allows
measurement of the proportion of cellular oxygen consumption
that is related to mitochondrial respiration. Antimycin reduced
OCR to similar levels in both unirradiated and irradiated OE33 P
and OE33 R cells (Figure 4A), suggesting that mitochondrial
respiration rates are similar in both cell lines. Antimycin-resistant
rates reflect non-mitochondrial respiration, which includes cell
surface oxygen consumption [25]. Cells were also treated with
oligomycin, which inhibits complex V where the electron transport
chain is coupled to ATP synthesis. Interestingly, OE33 R cells
were significantly more sensitive to oligomycin, when compared to
OE33 P cells, with oligomycin reducing OCR to ,43% and
,63% of baseline rates, respectively (Figure 4B). Irradiated OE33
P cells were also more sensitive to oligomycin, with OCR reduced
a further 24% when compared to unirradiated cells (from 63% to
39%). This effect was not observed in OE33 R cells.
OE33 R cells had a significantly increased percentage of
mitochondrial respiration linked to ATP turnover, when com-
pared to OE33 P cells (p=0.02) (Figure 4C), which supports the
demonstrated alterations in intracellular ATP levels. OE33 R cells
also had a significantly lower percentage of mitochondrial
respiration accounted for by proton leak (p=0.02), when
compared to OE33 P cells (Figure 4D). Proton leak is an
extremely energy-inefficient process, supporting the enhanced
metabolic activity of OE33 R cells. Interestingly, irradiated OE33
P cells had a trend towards increased ATP turnover and decreased
proton leak (p=0.053), when compared to unirradiated controls,
suggesting IR-induced metabolic changes in these cells. Combin-
ing these results (Figures 4E, F, G, H), the demonstrated
alterations in ATP turnover and proton leak in OE33 R cells
supports a role for altered bioenergetics in the radioresistance of
this model.
To investigate if alterations in glycolysis were involved in the
radioresistance of OE33 R, we treated both OE33 R and OE33 P
cells with the glycolytic inhibitor 2-deoxyglucose (2-DG)
(Figure 5A). Treatment with 2-DG reduced ECAR rates to 56%
and 55% from baseline, in OE33 P and OE33 R, respectively. A
similar reduction in ECAR following 2-DG treatment was also
Figure 2. OE33 R cells have increased basal numbers of mitochondria and display altered morphology. The ultrastructure of OE33 P (A,
C and E) and OE33 R cells (B, D and F) was assessed basally (A, B, E, F) and at 24 h post 2 Gy (C and D) by TEM. Representative images are shown. Black
arrows point to mitochondria.
doi:10.1371/journal.pone.0100738.g002
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seen in OE33 P and OE33 R cells at 24 h post irradiation with
2 Gy, with ECAR rates at 55% and 59% from baseline,
respectively. This suggests that the contribution of glycolysis to
energy metabolism is similar in both cell lines.
The reduction in OCR following oligomycin treatment
(Figure 4B) was accompanied with an increase in ECAR in both
cell lines, suggesting a switch from oxidative phosphorylation to
glycolysis (Figure 5B). Interestingly, ECAR was significantly higher
in OE33 R cells following oligomycin treatment when compared
to OE33 P cells (p=0.03), suggesting that radioresistant cells can
more efficiently switch to glycolysis following inhibition of
oxidative phosphorylation. Supporting this, OE33 R cells dem-
onstrated significantly enhanced clonogenic survival (p=0.02)
following treatment with oligomycin for 1.5 h, when compared to
OE33 P cells (Figure 5C).
Energy metabolism is altered in tumours from OAC
patients who have a poor response to neoadjuvant CRT
Having demonstrated alterations in both mitochondrial func-
tion and energy metabolism in an in vitro model of radioresistant
OAC, we then investigated if metabolic alterations would indicate
response to neoadjuvant CRT in OAC patient tumours. We
examined expression of four protein markers associated with
mitochondrial function and energy metabolism, HSP60, a
mitochondrial chaperone protein, ATP5B a marker of oxidative
phosphorylation and two markers of glycolysis, GAPDH and
PKM2. Expression of these proteins was assessed in 23 OAC
tumour tissue biopsies taken prior to neoadjuvant CRT, using
tissue microarrays and immunohistochemistry. In this patient
cohort, 30% were classified as ‘good’ responders (TRG 1 (n=2)
and 2 (n=5)), whilst 70% were classified as ‘poor’ responders
(TRG 3 (n=8), 4 (n=5) and 5 (n=3)). There was no significant
Figure 3. OE33 R cells display alterations in mitochondrial-associated gene expression, total cellular energy and energy
metabolism pathways. (A) Basal expression of 15 mitochondrial function and energy metabolism-associated genes were altered 1.5-fold in OE33 R
cells, when compared to OE33 P. Data are presented as mean 6 SEM from 2 independent experiments. (B) OE33 R cells have significantly increased
basal intracellular ATP levels, when compared to OE33 P. ATP levels significantly decrease in OE33 P cells at 24 h post irradiation with 2 Gy, when
compared to basal levels. Data are presented as mean 6 SEM from 1 independent experiment. (C) Basal oxygen consumption rates (OCR) are
significantly increased in OE33 R cells, when compared to OE33 P. Data are presented as mean 6 SEM from 4 independent experiments. (D) OE33 R
and OE33 P cells demonstrate similar extracellular acidification rates (ECAR). Data are presented as mean 6 SEM from 4 independent experiments.
Statistical analysis was performed by 2-tailed Student’s t-test, *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0100738.g003
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Figure 4. OE33 R cells have higher ATP turnover and reduced proton leak. (A) OE33 P and OE33 R cells demonstrate similar sensitivity to
antimycin (2.6 mM). (B) OE33 R cells were significantly more sensitive to the effects of oligomycin (2 mg/mL) on OCR, when compared to OE33 P cells.
At 24 h post 2 Gy, OE33 P cells were significantly more sensitive to the effects of oligomycin on OCR, when compared to unirradiated cells. (C) OE33 R
cells demonstrate significantly higher percentage of mitochondrial respiration coupled to ATP synthesis, when compared to OE33 P. (D) OE33 R cells
demonstrate significantly lower proton leak, when compared to OE33 P. Data are presented as mean6 SEM from at least 3 independent experiments.
Statistical analysis was performed by 2-tailed Student’s t-test, *P,0.05. The contribution of mitochondrial respiration to ATP synthesis in OE33 P (E),
OE33 R (F) at basal level and at 24 h post irradiation with 2 Gy (G and H).
doi:10.1371/journal.pone.0100738.g004
Figure 5. OE33 R cells are more metabolically robust. (A) OE33 P and OE33 R cells display similar sensitivities to the glycolytic inhibitor 2-
deoxyglucose (55 mg/mL). (B) ECAR is significantly increased in OE33 R cells following oligomycin treatment (2 mg/mL), when compared to OE33 P.
(C) OE33 R cells have significantly enhanced clonogenic survival following treatment with oligomycin (2 mg/mL) for 1.5 h, when compared to OE33 P
cells. Data are presented as mean6 SEM from at least 3 independent experiments. Statistical analysis was performed by 2-tailed Student’s t-test, *P,
0.05.
doi:10.1371/journal.pone.0100738.g005
Mitochondrial Alterations and Radioresistance
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difference in age between good and poor responders. Patient
cohort characteristics are outlined in Table 1.
Supporting the increased oxidative phosphorylation rates seen
in radioresistant cells in vitro, expression of ATP5B was signifi-
cantly higher (p=0.043, 95% confidence interval 255.50 to 2
0.93) in the tumour epithelium of patients who had a poor
response to neoadjuvant CRT (TRG 3–5), when compared to
good responder patients (TRG 1–2) (Figure 6C). In addition,
expression of ATP5B was significantly higher (p,0.032) in the
tumour epithelium of patients with no evident regression following
CRT (TRG 5), when compared to patients achieving a complete
or major pathological response (TRG 1 and TRG 2, respectively)
(Figure 6D). Similar stromal ATP5B expression was demonstrated
in both good and poor responders (Figure S1). There was no
significant association between epithelial ATP5B expression and
lymph node status or overall survival (data not shown). Similarly to
that demonstrated in vitro, expression of the glycolytic markers
GAPDH and PKM2 was similar in both the epithelium and
stroma of tumours from good and poor responders (Figure S1).
This supports our in vitro data and suggests that alterations in
mitochondrial function and energy metabolism, specifically
enhanced oxidative phosphorylation, is associated with the tumour
response to neoadjuvant CRT in OAC patients.
Discussion
Whilst the overall prognosis of oesophageal cancer is poor,
multi-modal approaches have improved outcomes in patients with
locally advanced disease, with a 3-year survival of 58% reported
for patients receiving neoadjuvant CRT in a recent multi-centre
clinical trial [6]. The elucidation of both underlying molecular
mechanisms and biomarkers of resistance to therapy is central to
improving the efficacy of treatment and survival of OAC patients.
Whilst there is strong evidence to support a role for altered
mitochondrial function and energy metabolism in tumourigenesis,
little is known about their role in the response to anti-cancer
therapy, specifically radiation.
The mitochondrial genome is highly susceptible to oxidative
damage, with mutations in the mitochondrial genome implicated
in both the initiation [26] and progression [27] of cancer. Here,
quantification of random mitochondrial mutations in an isogenic
model of radioresistant OAC revealed that radioresistant OE33 R
cells have significantly elevated basal levels of random point
mutations, when compared to OE33 P. Given that DNA is the
primary target for IR-induced damage, this may be explained by
the chronic irradiation of the OE33 R cell line during its
generation and is consistent with a previous study demonstrating
increased mitochondrial mutagenesis in the progeny of irradiated
cells [21]. Random mutations are not clonally expanded and
therefore may account for the genetic heterogeneity demonstrated
in tumours, which may have implications in the tumour response
to treatment [28]. These data suggest that the burden of
mitochondrial mutations in OE33 R cells may be important for
their resistance to IR. Accompanying the increased frequency of
random mutations, OE33 R mitochondria demonstrated alter-
ations in function, number, size and morphology. Using high
content screening analysis, radioresistant OE33 R cells demon-
strated elevated basal levels of ROS, which may be the effector of
the increased mitochondrial mutagenesis. IR-induced oxidative
alterations can persist following the initial exposure [29] and may
be passed on to unirradiated progeny [30]. Thus, the increased
ROS levels may be due to the chronic irradiation of this cell line
during its generation. Whilst ROS are critical mediators of IR-
induced damage [31], paradoxically, ROS also play important
Table 1. Patient cohort characteristics
(n=23)
Male 16
Female 7
Age (years)a 61 (44–75)
Clinical TNM Stage 2 Patients NS
0 1
I 0
IIa 11
IIb 2
III 7
IV 0
TRG
1 2
2 5
3 8
4 5
5 3
Nodal Status
N0 7
N1 16
Abbreviations: aValues given are mean (range); TNM, Tumour-node-metastasis clinical staging classification; NS, not specified; TRG, Tumour regression grade; N0,
indicates lymph node metastasis negative; N1, lymph node metastasis positive.
doi:10.1371/journal.pone.0100738.t001
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roles in the signalling of survival and proliferative pathways [32]
and thus may be important for the resistance of OE33 R cells to
radiation. Interestingly, whilst basal ROS levels were increased in
OE33 R cells, the converse was demonstrated post irradiation,
with ROS levels elevated in OE33 P cells only. This suggests that
the chronic state of oxidative stress in OE33 R cells renders them
more resistant to subsequent oxidative stress insults. Supporting
this, our previous work demonstrated significantly decreased levels
of IR-induced DNA damage in OE33 R cells at 24 h post
irradiation compared with radiosensitive OE33 P [20]. Interest-
ingly, we have previously demonstrated that OE33 R cells
maintain levels of the ROS scavenging enzyme glutathione
following irradiation [20], suggesting that the difference in ROS
levels between the OE33 P and OE33 R cell lines post irradiation
may be due to alterations in ROS scavenging.
OE33 R cells appeared to have increased basal numbers of
mitochondria. These mitochondria were much smaller when
compared to OE33 P mitochondria, perhaps explaining why there
were no significant alterations in overall mitochondrial mass. This
supports previous studies [33,34] that have demonstrated IR-
induced mitochondrial biogenesis, with one study correlating
mitochondrial content with the proportion of cells in the G2/M
phase of the cell cycle [35]. We have previously demonstrated that
OE33 R cells have significantly increased basal numbers of cells in
G2/M phase [20], which may suggest a mechanism for this
increased number of mitochondria. Radiation appeared to
increase the numbers of mitochondria in OE33 P cells, which
may partly account for the increased IR-induced ROS levels in
these cells. Morphologically, the mitochondria of OE33 P and
OE33 R were starkly altered, with OE33 R mitochondria more
elongated and condensed. This supports a previous study which
demonstrated similar morphological alterations, with mitochon-
dria elongated and condensed in an in vitro isogenic model of
chemoresistant colon cancer [36], suggesting mitochondrial
alterations as a common mechanism of resistance to cytotoxic
agents.
The mitochondria are the powerhouse of the cell. Given the
demonstrated alterations in mitochondrial function, number and
morphology in OE33 R cells, it was not surprising that
perturbations in energy levels and energy metabolism were also
demonstrated. Radioresistant OE33 R cells had increased
intracellular ATP levels both basally and following irradiation,
suggesting increased energy demand in these cells. Supporting this,
OE33 R cells were demonstrated to be more metabolically active,
with significantly increased basal oxidative phosphorylation rates.
This supports the functionality of the mitochondria in these cells
and, again, may explain the increased basal ROS levels. Given the
polygenic nature of radioresistance mechanisms, most of which are
likely to require ATP, this suggests that the increased ATP
demand is a driving force behind the metabolic alterations in these
cells. This supports a previous study, which demonstrated that the
maintenance of intracellular ATP levels following irradiation was
associated with a radioresistant phenotype in head and neck
cancer [37]. ATP has previously been demonstrated to reduce
radiation-induced DNA damage and inflammatory cytokine
production [38], which may suggest a mechanism for this
radioprotective effect. Interestingly, increased ATP levels have
also been implicated in the resistance of colon cancer cells to
chemotherapy [36], perhaps suggesting a common mechanism of
resistance.
Figure 6. ATP5B expression is increased in the tumour epithelium of poor responders. ATP5B expression was assessed by
immunohistochemistry in pre-treatment tumour biopsies from OAC patients who subsequently received neoadjuvant CRT (n=23). Representative
images of ATP5B staining in tumours from good (A) and poor (B) responders, magnification 106. (C) ATP5B positivity in the epithelium is significantly
increased in tumours of patients with a poor response to neoadjuvant CRT (TRG 3–5), when compared to good responders (TRG 1 and 2). (D) ATP5B
positivity in the epithelium is significantly increased in tumours of patients with no evidence of regression (TRG 5), when compared to patients
achieving a full (TRG 1) or major response (TRG 2). Statistical analysis was performed by unpaired 2-tailed Student’s t-test, *P,0.05.
doi:10.1371/journal.pone.0100738.g006
Mitochondrial Alterations and Radioresistance
PLOS ONE | www.plosone.org 10 June 2014 | Volume 9 | Issue 6 | e100738
In addition to being more metabolically active, the bioenergetics
of OE33 R cells were also altered, with a significantly higher
proportion of mitochondrial respiration contributed to ATP
synthesis, supporting the elevated intracellular ATP levels in these
cells. Interestingly, irradiated OE33 P cells showed a similar
contribution of mitochondrial respiration to ATP synthesis,
although this was not reflected at the intracellular ATP level.
These data support a previous study that correlated increased
oxidative phosphorylation and ATP levels with radioresistance in
glioma cancer stem cells [39].
Whilst there was a trend towards increased basal glycolysis in
OE33 R cells, this was not statistically significant. OE33 P and
OE33 R cells displayed similar sensitivities to the glycolytic
inhibitor 2-deoxyglucose, suggesting that both cell lines have a
similar dependence on glycolysis. This is in contrast to a study by
Zhou and colleagues [36] that demonstrated enhanced glycolytic
rates as a mechanism for the chemoresistance of colorectal cells,
although their demonstrated correlation between ATP levels and
resistance to chemotherapy is in line with our data. Interestingly,
the ECAR rate was significantly increased in OE33 R cells
following inhibition of oxidative phosphorylation, which was
coupled with enhanced clonogenic survival following treatment
with oligomycin. This may suggest that radioresistant cells have a
metabolic plasticity, which allows them to efficiently switch to
alternative metabolic pathways if required.
It is acknowledged that this in vitro cell line model of
radioresistant OAC is a model of acquired radioresistance.
However, our in vitro data was supported in vivo, with the
functional subunit of ATP Synthase, ATP5B, significantly
increased in the tumours of OAC patients who were shown to
have a poor response to CRT. We have previously demonstrated
that OE33 R and OE33 P have similar sensitivities to cisplatin and
5-FU [20]. This suggests that the alterations in ATP5B expression
in vivo, may be predominantly involved in the cellular response to
radiation. Similarly to that demonstrated in vitro, expression of the
glycolytic markers GAPDH and PKM2 were not significantly
altered between good and poor responders. This supports the
clinical applicability of this isogenic radioresistant model, and
suggests that a metabolic shift to aerobic respiration may be a
mechanism of resistance to neoadjuvant CRT in OAC tumours.
Whilst oxidative phosphorylation was significantly increased in
radioresistant cells in vitro, levels of ATP5B were similar in both
OE33 P and OE33 R cells, basally and following irradiation with
2 Gy (Figure S2), suggesting that the increased mitochondrial
respiration in OE33 R is likely to involve multiple proteins
involved in this complex metabolic pathway.
The Warburg effect is considered a characteristic of cancer cells
[17]. However, adding to the complexity of cancer metabolism,
several studies have demonstrated active oxidative phosphoryla-
tion in numerous tumour types [18,40], and there is even evidence
of a metabolic symbiosis between hypoxic and oxygenated cells
within the same tumour [19], supporting a spectrum of cancer
bioenergetic profiles. This is supported in this study, where
ATP5B, HSP60, GAPDH and PKM2 were all demonstrated to be
significantly increased in the tumour epithelium, when compared
to the stromal compartment in OAC tumour biopsies (Figure S3).
Whilst this may be reflective of differences in proliferative capacity
between the two tissue compartments, this data demonstrates that
both oxidative phosphorylation and glycolysis are active in these
tumours.
The ability of tumour cells to adapt and reprogram their
metabolism in response to both internal and external factors is
now recognised as a hallmark of cancer [41]. Aerobic respiration is
the most efficient process of ATP generation, yielding 38 ATP
molecules when compared to 2 ATP molecules generated per
glucose molecule from glycolysis [42]. Given the potential for
increased energy demand in radioresistant cells, this metabolic
reprogramming may provide an advantage for surviving the
cytotoxic effects of IR. In addition, this metabolic shift is likely to
increase oxidative stress via the generation of free radicals from the
electron transport chain. Increasing evidence suggests that a
chronic state of oxidative stress facilitates tumour resistance to
subsequent oxidative stress inducers via the development of a
stable oxidative stress-resistant phenotype [43] and/or promotion
of genomic instability [44]. Interestingly, evidence suggests that
DNA repair pathways, such as Base Excision Repair (BER) and
Mismatch Repair (MMR) may be induced in mitochondria during
oxidative insult [45,46]. We have previously demonstrated that
levels of DNA repair genes, including genes of the BER and MMR
pathways, are increased in the tumours of patients who have a
poor response to CRT [24], supporting increased oxidative stress
in tumours of poor responders. A role for mitochondrial
dysfunction has been demonstrated in the persistence of oxidative
stress and genomic instability [47], which may facilitate a
metabolic plasticity that is important for tumour survival following
radiation and chemotherapy.
This study demonstrates for the first time a role for mitochon-
drial dysfunction and metabolic reprogramming in the radioresis-
tance of OAC. Elucidating the role of the mitochondria and
energy metabolism in the response of tumours to radiation therapy
may allow the prediction of response to treatment and the
identification of novel strategies and drug combination to enhance
the efficacy of treatment.
Supporting Information
Figure S1 Immunohistochemical staining in pre-treat-
ment OAC tumours. Stromal expression of (A) ATP5B, (C)
HSP60, (E) GAPDH, (G) PKM2 and epithelial expression of (B)
HSP60, (D) GAPDH, (F) PKM2 was assessed in pre-treatment
OAC biopsies from patients who subsequently had a good (n=7)
or poor (n=16) response to neoadjuvant CRT.
(TIF)
Figure S2 ATP5B expression in OE33 P and OE33 R.
ATP5B expression was assessed in OE33 P and OE33 R, basally
and at 6 h and 24 h post irradiation with 2 Gy by (A) qPCR and
(B) western blotting. Data are presented as the mean 6 SEM from
3 independent experiments. (C) Representative western blot.
(TIF)
Figure S3 Metabolism is increased in the tumour
epithelium in pre-treatment OAC tumours. Expression
(percentage positivity and intensity) of ATP5B (A and B), HSP60
(C and D), GAPDH (E and F) and PKM2 (G and H) was
assessed in the stromal and epithelial compartments in pre-
treatment OAC biopsies (n=23). Statistical analysis was per-
formed by paired 2-tailed Student’s t-test or Wilcoxon non-
parametric test. **P,0.01, ***P,0.001.
(TIF)
File S1
(DOCX)
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